Diabetic Neuropathy market to reach USD 8.18 billion by 2032 and grow at a CAGR of 7.48%
This report offers comprehensive insights into key trends shaping the prescription drugs market, including drug pricing trends that reflect the evolving strategies in cost management and market accessibility. It also delves into the regulatory approvals and market authorization process, highlighting how stringent regulations influence drug launches and market dynamics.